Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.

Higher education level ( P = 0.071) and prior use of tamoxifen ( P = 0.088) were also associated with early discontinuation but did not reach statistical significance (Table 1 ).

also in 111,027 other papers